Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evaluation of cofactor responsiveness.

J V Leonard, P Daish

    Journal of Inherited Metabolic Disease
    |January 1, 1985
    PubMed
    Summary

    Cofactor therapy for inborn errors of metabolism can fully resolve illness, but responses are often partial or absent. Evaluating treatment effectiveness requires considering clinical, biochemical, and natural history data.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Enzyme studies in combined carboxylase deficiency.

    Annals of the New York Academy of Sciences·2015
    Same author

    Pricing of orphan drugs.

    Lancet (London, England)·2009
    Same author

    Newborn screening for medium chain acyl CoA dehydrogenase deficiency.

    Archives of disease in childhood·2008
    Same author

    Causes of and diagnostic approach to methylmalonic acidurias.

    Journal of inherited metabolic disease·2008
    Same author

    Neurological implications of urea cycle disorders.

    Journal of inherited metabolic disease·2007
    Same author

    Recent advances in amino acid and organic acid metabolism.

    Journal of inherited metabolic disease·2007

    Area of Science:

    • Biochemistry
    • Genetics
    • Metabolic Disorders

    Background:

    • Inborn errors of metabolism (IEMs) are genetic disorders affecting metabolic pathways.
    • Cofactor therapy is a treatment strategy for certain IEMs, aiming to supplement deficient or dysfunctional cofactors.
    • The clinical and biochemical outcomes of cofactor therapy in IEMs are variable.

    Purpose of the Study:

    • To review the variability in patient responses to cofactor therapy in inborn errors of metabolism.
    • To highlight the importance of comprehensive assessment in predicting treatment success.
    • To provide guidance on evaluating cofactor responsiveness in IEMs.

    Main Methods:

    • Literature review of studies reporting cofactor therapy outcomes in IEMs.
    • Analysis of clinical case reports and biochemical data.
    • Synthesis of information on the natural history of relevant IEMs.

    Main Results:

    • Complete resolution of clinical symptoms is possible with cofactor therapy but not the typical outcome.
    • Absent or partial responses to cofactor therapy are more common across various IEMs.
    • Factors influencing response include the specific IEM, cofactor used, and individual patient characteristics.

    Conclusions:

    • Cofactor responsiveness in IEMs is complex and heterogeneous.
    • A thorough evaluation integrating clinical presentation, biochemical markers, and the disorder's natural course is crucial for assessing treatment efficacy.
    • Individualized treatment approaches are necessary for optimizing outcomes in cofactor-responsive IEMs.

    Related Experiment Videos